← Valuations

Voyager Technologies (VOYG)

Defense & space tech: solid-rocket propulsion/energetics, missile-defense subsystems, space hardware, Astrobotic lunar landers · 67% owner of the Starlab commercial space station JV · Denver, CO · IPO June 2025 at $31
Pre-profit → segment SOTP: core FCFF (SBC expensed) + Starlab probability tree · reverse DCF · converts at straight-debt value · valued 2026-10-15
OVERVALUEDRISK: VERY HIGH
Price $25.93 · Base $4.15 · Price is +525% above base

What they do

Voyager is a government contractor that is trying to become a space-station operator. Today almost all of its revenue comes from the Defense & Space Technologies segment. In Q2 FY26, 93% of sales were to the U.S. government (NASA, Missile Defense Agency, DoD primes), 7% commercial, and almost nothing international. The segment sells solid-rocket propulsion and divert/attitude-control hardware for interceptors. It has a $500M+ build-out of the "American Defense Complex" in Pueblo, CO, sized for 15–20k propulsion units a month, and signed a $60M+ Anduril supply deal on 9/29. It also sells space hardware, airlocks and payload services, and power/thermal subsystems. Since the July 2026 Astrobotic acquisition (up to $300M), it builds lunar landers, including a new $298M NASA lander award, with an expected $60–70M annual run-rate. It makes money on cost-plus and fixed-price government contracts. Margins are thin today (Q2 gross margin 8%; management guides ~17% in Q3 and >20% in Q4).

The Starlab Space Stations segment has no revenue. It is a $2.8–3.3B single-launch commercial station (Starship, targeted 2029) to replace the ISS. Voyager owns ~67%, Airbus 30.5%, and Palantir, Mitsubishi and MDA hold small stakes. Starlab has collected $183M of a $217.5M NASA Phase-1 Space Act Agreement and holds over $500M of commercial reservations. Its economics depend on one decision: whether NASA picks Starlab as its anchor tenant. In March 2026 NASA said it now has budget for only one provider and floated an ISS-attached government core module instead. Key sensitivities: defense propulsion volumes and margins, NASA's 2026–27 commercial-station decision, cash burn (FY25 FCF −$155M; H1 FY26 −$140M), and dilution from $862.5M of converts plus ongoing SBC and stock-funded M&A.

Price (10/15 intraday)
$25.93
Base intrinsic value
$4.15
Bear → Blue-sky · prob-wtd
−$1.73 – $24.46 · $6.31
Key driver
Core steady margin; price needs ~33% EBIT (vs 12% base)

The Take — A real defense-propulsion growth story inside a valuation that's already priced past the blue-sky case. Don't own it here.

The operating momentum is genuine. FY26 revenue guidance went from $225–255M in March to $275–305M in August (+66–84%). Q2 bookings were a record $113M (2.1× book-to-bill), and backlog reached a record $336M. The Astrobotic deal brought a $298M NASA lander award, and the Anduril propulsion deal shows the Pueblo plant has customers. Defense propulsion is a real bottleneck in U.S. munitions, and Voyager is one of the few new entrants with capacity coming online. I give the core business a generous path: revenue 4.2× to $1.23B by 2035 and a 12% steady-state EBIT margin, with SBC expensed. That margin is above what Kratos or Mercury earn and close to Curtiss-Wright/BWXT economics.

The cash math is the problem. The core business is still losing money: H1 FY26 clean operating loss was about $87M on $88M of revenue, and corporate cost alone was $46M in FY25. Free cash flow was −$155M in FY25 and −$140M in H1 FY26. Even on my base path the core doesn't generate positive FCFF until 2031, and it absorbs ~$600M of reinvestment through 2035. Discounted at an 11.8% WACC, the core is worth $465M. Explicit-period FCFF has a negative PV, so 123% of core value sits in the terminal value. That is a flag, not a comfort.

Starlab is an option, and on today's facts it's worth less than zero. If NASA picks Starlab (I assume ~$1.0B of Phase-2 funding, launch 2030, $1.2B/yr of revenue at 40% EBITDA margins by 2035), the whole project NPV at a 13% project rate is about −$54M. The remaining ~$2.6B of build cost eats the operating value. If NASA picks someone else (Axiom and Vast are further along in hardware), Voyager's 67% share of another ~$250M of spend before exit is a pure loss. At a 40% win probability, Starlab is worth −$108M to VOYG holders. For the price to work, Starlab would need to be worth ~$1.27B to Voyager (~$1.9B for the whole station). That is a certain win at well above blue-sky economics.

Reverse DCF: to reach $25.93 at my base growth path and base Starlab, the core needs a ~33% EBIT margin forever. That's software economics for a solid-rocket-motor shop. Holding a 12% margin, it needs 2.5× my growth rates every year. Even with a 16% margin and a guaranteed Starlab win, the core must grow at 1.9× base. My blue-sky case gets 1.6× growth, a 16% margin, a 2029 launch and a $1.6B/yr station, and it still lands at $24.46, below the price. The market is paying for a strategic-scarcity narrative ("one of the only U.S. commercial stations plus new SRM capacity"), not for cash flows.

This is the first build; there is no prior valuation. Street: 8 Buy / 2 Sell, mean target $44.50 (range $21–55). The Street is valuing it on EV/sales multiples. I am valuing it on cash.

Call: AVOID / SELL. No new money above the bull case ($10.69); value support isn't until single digits (prob-weighted $6.31). Holders: sell into strength, especially any NASA-decision or contract-award spike back toward the $31–33 late-September range. If you insist on exposure, treat it as a venture option capped at ≤0.5% of capital and accept that the base case is worth a sixth of the price. Q3 FY26 print Nov 2 after close, the first quarter with Astrobotic. The gross-margin step to ~17% is the tell. Defined-risk expression: Dec-18 or Jan-15 $30/$35 bear call spread. Dec IV is ~78–88%, and the mid is about $0.60–0.70 credit on $5 of width, but the chain is thin (zero open interest, very wide quotes), so work limit orders at the mid or skip it. Covered calls at $30–32 strikes for holders who won't sell outright. Never short it naked. Float is ~53M shares, and one NASA "Starlab selected" headline could gap it 30–50%.

Risk Profile — VERY HIGH

HIGHNASA commercial-station decision (binary). NASA has budget for one provider, an ISS-attached core-module alternative is under study, and GAO says the go/no-go on ISS retirement comes in 2027. Long Starlab selection; short a NASA pivot to an ISS-attached path or to Axiom/Vast. This is a headline risk in both directions and the stock's biggest event.
HIGHCash burn / funding gap. FCF −$155M (FY25), −$140M (H1 FY26). Starlab's remaining ~$2.6B build is far larger than VOYG's ~$620M pro-forma cash. Expect more converts or equity, partner dilution, or project debt. Short capital markets closing on unprofitable space names.
HIGHExecution on margin ramp. Q2 gross margin was 8%. The path to 17%/20%+ depends on fixed-price propulsion programs ramping cleanly at Pueblo. Long volume absorption; short cost overruns on fixed-price defense work.
MEDDilution & capital structure. $460M 0.75% 2030 notes (conv. $30.98) and $402.5M 0% 2032 notes (conv. $40.82), partly offset by capped calls to $59.58 / $78.50. Add the Astrobotic stock earn-out, SBC (~$19M in FY25) and serial stock M&A (five deals in 2025).
MEDDefense budget / customer concentration. 93% U.S. government. Long Golden Dome / munitions replenishment; short continuing resolutions and shutdowns (the March guide already cited shutdown uncertainty).
LOWNear-term solvency. ~$620M pro-forma cash plus a $212M undrawn revolver, and the earliest debt maturity is 2030. No 2026–27 liquidity crisis. The risk is value erosion, not default.
What the real bet is: you are long the core margin and NASA's pick, and short the remaining Starlab capital bill. The tornado's widest bars are the core steady-state margin and the discount rate, which are both duration effects of a business that doesn't make money until ~2030. The Starlab win probability matters less than you'd think, because on realistic build-cost and funding assumptions even a win is roughly NPV-neutral. The equity is a leveraged call on (a) defense propulsion becoming a 15%+ margin franchise and (b) NASA paying far more than $1B for Starlab.

Scenario values per share vs price

Bear−$1.73 (equity under water)Base$4.15Bull$10.69Blue-sky$24.46Prob-wtd$6.31Price$25.93
Bear: core 0.65× growth path, 8% margin; Starlab loses NASA and winds down. Base: core $1.23B 2035 revenue, 12% margin; Starlab 40% win (2030 launch). Bull: 1.3× path, 14% margin; Starlab certain win. Blue-sky: 1.6× path, 16% margin; Starlab wins, launches 2029 and reaches $1.6B/yr. Prob-weighted 20/50/20/10 = $6.31. All cases carry the same claims: ~$600M straight-debt value of the converts, $42M leases, ~$60M Astrobotic earn-out (est.), 63.0M diluted shares.

Driver tornado: Δ value/share from base $4.15

Core steady margin ±3pt$0.96$7.32WACC ±100bp$2.06$7.19Core growth path ±25%$2.54$6.17Sales-to-capital ±25%$2.39$5.20Starlab steady rev ±25%$2.91$5.39Starlab win prob 20% / 60%$3.77$4.53Terminal g ±0.5pt$3.84$4.52

Master-driver grid: value/share by core revenue path × steady-state EBIT margin (base Starlab)

Core rev path (2031 rev) ↓ / steady EBIT margin →8%10%12%14%16%18%20%
0.6× path ($602M)−$1.09$0.34$1.74$3.08$4.42$5.75$7.08
0.8× path ($750M)−$0.60$1.13$2.83$4.52$6.21$7.90$9.58
1.0× path ($924M)−$0.10$2.02$4.15$6.27$8.38$10.50$12.61
1.2× path ($1,130M)$0.46$3.10$5.73$8.36$10.99$13.62$16.24
1.4× path ($1,370M)$1.13$4.38$7.62$10.86$14.10$17.34$20.58
Green = above price $25.93; yellow = within ±5%; orange = up to 30% below; red = more than 30% below. No cell on this grid reaches the price. You need ~33% margins at 1.0×, or ~2.5× growth at 12%.

Starlab option grid: value/share by NASA-selection probability × station steady-state revenue

P(NASA picks Starlab) ↓ / steady-state station revenue →$0.8B/yr$1.2B/yr$1.6B/yr
0%$3.39$3.39$3.39
20%$2.94$3.77$4.60
40%$2.49$4.15$5.81
60%$2.04$4.53$7.01
80%$1.59$4.90$8.22
100%$1.14$5.28$9.42
Each cell holds the core at base and changes only Starlab. Revenue scale matters more than win probability. At $0.8B/yr a win destroys value (higher probability lowers the number) because build cost exceeds operating value. Remaining build cost $2.6B (est.: $3.05B midpoint less ~$450M spent to date), NASA Phase-2 $1.0B (est.), 13% project discount rate.

Sensitivity: value/share by WACC (high-growth → stable) × terminal growth

WACC (high-growth → stable) ↓ / g →2.0%2.5%3.0%3.5%
9.8% → 6.7%$9.71$10.70$11.96$13.60
10.8% → 7.7%$6.07$6.58$7.19$7.94
11.8% → 8.7%$3.56$3.84$4.15$4.52
12.8% → 9.7%$1.76$1.90$2.06$2.24
13.8% → 10.7%$0.40$0.47$0.55$0.64

History: revenue (blue; FY26 = guidance midpoint), GAAP EBIT (orange) and clean EBIT margin (green)

$136MFY23$144M−$48MFY24$166M−$108MFY25$88M−$96MH1 FY26$290MFY26 guide−22.8%−58.8%−98.9%
FY23 operating detail not available from the sources used (FY23 net loss −$25.4M). H1 FY26 is six months. Clean EBIT = GAAP EBIT + acquired-intangible amortization + impairment/restructuring; SBC stays expensed. Margins are worsening as the company scales Starlab and corporate cost, while revenue growth is only now inflecting.

Normalization worksheet & R&D capitalization ($M)

PeriodRevenueGAAP EBITAcq. amortOne-offsClean EBITMarginR&DSBCStarlab seg. adj EBITDA
FY2024$144.2−$48.4$9.6$5.9−$32.9−22.8%$7.6$3.8−$14.1
FY2025$166.4−$108.5$8.5$2.1−$97.9−58.8%$12.8$18.9−$18.7
H1 FY2026$88.0−$96.1$9.1n/d−$87.0−98.9%$14.8$7.9n/d
Normalized (historical-average) marginNot meaningful: no profitable year to normalize to
Normalization lens used instead: peer steady-state EBIT (Kratos ~5%, Mercury ~5–8%, AeroVironment ~10%, L3Harris ~15%, BWXT/Curtiss-Wright ~17–18%)12% base (8% bear / 16% blue-sky)
FY25 core vs Starlab split: DST segment adj EBITDA / Starlab / corporate−$5.3 / −$18.7 / −$45.9
Starlab capex (capitalized, not in EBIT): FY24 / FY25$79.4 / $137.5
Research asset (10-yr SL, defense; FY22–23 R&D est. $5M/yr, FY26 = H1×2)$53.8
FY26E R&D $29.7 − amortization $3.0 = EBIT add-back+$26.7
R&D capitalization is shown for completeness. It is FCFF-neutral here (expensed R&D becomes reinvestment, and VOYG pays no cash tax while it carries ~$400M of NOLs, est.), and the research asset is immaterial against ~$620M of invested capital ex-Starlab. Management says internally funded R&D is ~20% of FY26 revenue across COGS/SG&A, which is larger than the $14.8M reported R&D line. One-offs: FY24 impairment $3.6M + restructuring $2.3M; FY25 restructuring $2.1M.

Why not a standard single-entity FCFF

A consolidated FCFF would blend a scaling defense manufacturer with a $2.6B pre-revenue construction project that has a binary government funding event and 33% outside owners. A consolidated growth rate or margin means nothing for either piece. I split it: (1) a 10-year FCFF on the core (Defense & Space Technologies, Astrobotic, all corporate cost), starting from a 2026 H2 stub built off guidance; (2) Starlab as a project NPV at 100% (build spend net of NASA funding, then 25 years of operations) × 67%, probability-weighted between win and wind-down; (3) a reverse DCF to show what the price requires. The converts are valued at straight-debt PV plus residual uncapped option value, which is how Damodaran treats hybrids. Carrying them at face would cut ~$4.17/share more.

Base-case core FCFF ($M; valuation date 7/1/2026)

YearRevenuegMarginEBITNOPATReinvestFCFFWACCPV
2026 H2$202—−19.8%−$40−$40$45−$8511.82%−$83
2027$40640.0%−8.0%−$32−$32$68−$10111.82%−$85
2028$53632.0%1.0%$5$5$76−$7111.82%−$54
2029$67025.0%6.0%$40$40$79−$3911.82%−$26
2030$80420.0%9.0%$72$72$79−$611.82%−$4
2031$92415.0%11.0%$102$102$71$3111.82%$17
2032$1,02611.0%12.0%$123$123$60$6311.03%$31
2033$1,1088.0%12.0%$133$132$48$8410.25%$37
2034$1,1756.0%12.0%$141$109$39$699.47%$28
2035$1,2284.5%12.0%$147$113$31$828.68%$31
Sum PV FCFF (2026 H2–2035)−$108
Terminal value (g 3.0%, ROIC 12%, reinvest 25%, stable WACC 8.68%)$1,542
PV terminal value · share of core value (>70%: flagged; explicit period is net cash-negative)$573 · 123%
Core operating asset value$465
Stub: 2026 H2 revenue $202M (guide midpoint less H1), EBIT −$40M, reinvestment $45M (est.). Tax 0% until ~$400M NOLs (est.) are used, then 23%. Sales-to-capital 1.7.
Starlab win-case project NPV (100%) · wind-down case (100%)−$54 · −$232
Starlab value to VOYG (67% × [40% win + 60% wind-down])−$108

Cost of capital

Risk-free (10Y UST)5.20%
Equity risk premium4.40%
Bottom-up unlevered beta (blend: aerospace & defense ~0.95, space/new-space ~1.6)1.30
Market D/E (convert straight-debt value + leases ≈ $642M / mkt cap $1,634M)39.3%
Levered beta1.694
Cost of equity12.65%
Pre-tax cost of debt (synthetic B: negative coverage; Rf + 4.5%). No tax shield while loss-making9.70% → 9.70%
Debt weight28.2%
WACC: high growth (2026–31), gliding over 2032–35 to11.82%
Stable WACC (β 1.0, 20% debt at 6.5% pre-tax, 23% tax)8.68%
Starlab project discount rate (development-stage infrastructure)13.0%

Inputs & equity bridge ($M, 6/30/26 pro forma for Sept-26 notes and Astrobotic)

Core operating asset value$465
+ Starlab (67%, probability-weighted)−$108
+ Cash: $373.4 (6/30) + $339.1 Sept-26 notes net of capped call − $90 Astrobotic cash at close (est.)$622
− 0.75% 2030 converts, $460M face at straight-debt PV (9.7%)($329)
− 0% 2032 converts, $402.5M face at straight-debt PV($230)
− Conversion options net of capped calls (est.)($40)
− Operating lease liabilities($42)
− Astrobotic contingent consideration (est.; deal "up to ~$300M")($60)
− Partners' 33% of Starlab VIE cash ($48.4M)($16)
Equity value$262
÷ Diluted shares: 55.27M Class A + 5.76M Class B (7/31/26 cover) + ~2.0M awards (est.)63.03M
Value per share$4.15
Not adjusted: the ~5.5M-share prepaid forward from Nov-25 (shares return to VOYG in 2030). Excluding them would add ~$0.40/share at baseupside item
Street: 8 Buy / 0 Hold / 2 Sell, mean target $44.50 (range $21–55)Base is −91% vs mean target
Sources: Voyager Q2 FY26 earnings release / 8-K (Aug 3, 2026) and Q2 10-Q (Aug 4, 2026); FY25 earnings release (Mar 9, 2026) and segment-recast 8-K Ex. 99.1 (Aug 2026); convertible note pricing releases (Nov 6, 2025; Sept 23 and 28, 2026); Astrobotic 8-K (Jun 1, 2026) and closing release (Jul 13, 2026); Anduril partnership (Sept 29, 2026); S-1/IPO coverage (Washington Technology, Motley Fool, May–Jun 2025) for Starlab ownership, cost and NASA SAA; Aerospace America (Mar 25 and Apr 16, 2026) and GAO-26-107805 (Jun 17, 2026) on NASA's commercial-station strategy; Q2 call summary (Quartr); Robinhood quote, fundamentals, analyst ratings, earnings calendar and option chain (10/15/26). Items marked "est." are my estimates, not disclosed figures. FY23 operating detail and post-IPO Starlab ownership changes ($19.1M of NCI sold in H1 FY26) were not available. Q3 FY26 earnings Nov 2 after close. Educational analysis, not investment advice.